Emerging Company Profile
With crossover funding already in place, Stagliano’s Neuron23 exits stealth with programs in neurology, systemic immune disease
Emerging Company Profile: Westlake Village start-up’s partnership with Germany’s Origenis yields candidates against two targets
A partnership with Germany’s Origenis gives the Westlake Village-backed biotech candidates against two targets.
Dec 16, 2020 | 1:49 PM GMT
After two years in